John B Moriarty Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John B Moriarty.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John B Moriarty. John B Moriarty is EVP & General Counsel in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP & General Counsel in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, General Counsel in PORTOLA PHARMACEUTICALS INC ($PTLA).
Latest Insider Trading Transactions of John B Moriarty
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2020 | PTLA | PORTOLA PHARMACEUT ... | Moriarty John B | EVP, General Counse ... | Option Exercise | A | 0.00 | 73,125 | 0 | 73,125 | |
| Feb 04 2020 | PTLA | PORTOLA PHARMACEUT ... | Moriarty John B | EVP, General Counse ... | Option Exercise | A | 12.79 | 65,000 | 831,350 | 65,000 | |
| Feb 04 2020 | PTLA | PORTOLA PHARMACEUT ... | Moriarty John B | EVP, General Counse ... | Payment of Exercise | F | 12.89 | 3,544 | 45,682 | 53,184 | 56.7 K to 53.2 K (-6.25 %) |
| Feb 04 2020 | PTLA | PORTOLA PHARMACEUT ... | Moriarty John B | EVP, General Counse ... | Grant | A | 0.00 | 16,250 | 0 | 56,728 | 40.5 K to 56.7 K (+40.15 %) |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Moriarty John B | EVP, General Counse ... | Option Exercise | A | 27.10 | 75,000 | 2,032,500 | 75,000 | |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Moriarty John B | EVP, General Counse ... | Grant | A | 0.00 | 18,750 | 0 | 43,750 | 25 K to 43.8 K (+75.00 %) |
| Mar 30 2018 | PTLA | PORTOLA PHARMACEUT ... | Moriarty John B | EVP, General Counse ... | Option Exercise | A | 32.66 | 125,000 | 4,082,500 | 125,000 | |
| Mar 30 2018 | PTLA | PORTOLA PHARMACEUT ... | Moriarty John B | EVP, General Counse ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 115.70 | 1,200 | 138,840 | 74,537 | 75.7 K to 74.5 K (-1.58 %) |
| Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 115.70 | 2,163 | 250,259 | 75,737 | 77.9 K to 75.7 K (-2.78 %) |
| Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 6,500 | 0 | 77,900 | 71.4 K to 77.9 K (+9.10 %) |
| Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 21,489 | 0 | 71,400 | 49.9 K to 71.4 K (+43.05 %) |
| Feb 07 2018 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 117.26 | 1,261 | 147,865 | 49,911 | 51.2 K to 49.9 K (-2.46 %) |
| Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Option Exercise | A | 131.25 | 12,800 | 1,680,000 | 12,800 | |
| Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 6,500 | 0 | 51,172 | 44.7 K to 51.2 K (+14.55 %) |
| Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 132.50 | 282 | 37,365 | 44,672 | 45 K to 44.7 K (-0.63 %) |
| Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 131.71 | 910 | 119,856 | 44,954 | 45.9 K to 45 K (-1.98 %) |
| Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 131.20 | 612 | 80,294 | 45,864 | 46.5 K to 45.9 K (-1.32 %) |
| Feb 10 2017 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 126.84 | 167 | 21,182 | 46,476 | 46.6 K to 46.5 K (-0.36 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 128.09 | 135 | 17,292 | 46,643 | 46.8 K to 46.6 K (-0.29 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 126.38 | 23 | 2,907 | 46,778 | 46.8 K to 46.8 K (-0.05 %) |
| Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 125.69 | 3,380 | 424,832 | 46,801 | 50.2 K to 46.8 K (-6.74 %) |
| Dec 13 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 118.61 | 1,044 | 123,829 | 50,181 | 51.2 K to 50.2 K (-2.04 %) |
| Aug 10 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 137.14 | 135 | 18,514 | 51,225 | 51.4 K to 51.2 K (-0.26 %) |
| Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Option Exercise | A | 140.16 | 31,000 | 4,344,960 | 31,000 | |
| Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 140.65 | 1 | 141 | 52,278 | 52.3 K to 52.3 K (0.00 %) |
| Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 138.91 | 1,200 | 166,692 | 52,279 | 53.5 K to 52.3 K (-2.24 %) |
| Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 5,000 | 0 | 53,479 | 48.5 K to 53.5 K (+10.31 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 138.02 | 2,418 | 333,732 | 48,501 | 50.9 K to 48.5 K (-4.75 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 140.21 | 78 | 10,936 | 50,919 | 51 K to 50.9 K (-0.15 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 138.02 | 137 | 18,909 | 50,997 | 51.1 K to 51 K (-0.27 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 141.75 | 433 | 61,378 | 51,134 | 51.6 K to 51.1 K (-0.84 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 142.18 | 436 | 61,990 | 51,567 | 52 K to 51.6 K (-0.84 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 143.44 | 200 | 28,688 | 52,003 | 52.2 K to 52 K (-0.38 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 144.39 | 400 | 57,756 | 52,203 | 52.6 K to 52.2 K (-0.76 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 145.27 | 500 | 72,635 | 52,603 | 53.1 K to 52.6 K (-0.94 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 11,763 | 0 | 53,103 | 41.3 K to 53.1 K (+28.45 %) |
| Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 185.54 | 25 | 4,639 | 41,340 | 41.4 K to 41.3 K (-0.06 %) |
| Dec 15 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 182.65 | 918 | 167,673 | 41,365 | 42.3 K to 41.4 K (-2.17 %) |
| Aug 11 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 190.01 | 135 | 25,651 | 42,283 | 42.4 K to 42.3 K (-0.32 %) |
| Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Option Exercise | M | 92.65 | 10,000 | 926,500 | 45,000 | |
| Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Buy | M | 92.65 | 10,000 | 926,500 | 42,418 | 32.4 K to 42.4 K (+30.85 %) |
| Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 199.05 | 3,436 | 683,936 | 32,418 | 35.9 K to 32.4 K (-9.58 %) |
| Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 198.12 | 6,574 | 1,302,441 | 35,854 | 42.4 K to 35.9 K (-15.49 %) |
| Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Buy | M | 92.65 | 10,000 | 926,500 | 42,428 | 32.4 K to 42.4 K (+30.84 %) |
| Jun 12 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 170.00 | 914 | 155,380 | 32,428 | 33.3 K to 32.4 K (-2.74 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Option Exercise | A | 180.37 | 5,874 | 1,059,493 | 5,874 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 180.34 | 280 | 50,495 | 33,342 | 33.6 K to 33.3 K (-0.83 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 1,745 | 0 | 33,622 | 31.9 K to 33.6 K (+5.47 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 5,100 | 0 | 31,877 | 26.8 K to 31.9 K (+19.05 %) |
| Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 171.15 | 1,490 | 255,014 | 26,777 | 28.3 K to 26.8 K (-5.27 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 174.16 | 1,455 | 253,403 | 28,267 | 29.7 K to 28.3 K (-4.90 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 8,760 | 0 | 29,722 | 21 K to 29.7 K (+41.79 %) |
| Dec 15 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 195.53 | 3,570 | 698,042 | 20,962 | 24.5 K to 21 K (-14.55 %) |
| Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Option Exercise | M | 92.65 | 10,000 | 926,500 | 12,812 | |
| Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Sell | S | 190.00 | 73 | 13,870 | 24,532 | 24.6 K to 24.5 K (-0.30 %) |
| Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Sell | S | 189.49 | 9,927 | 1,881,067 | 24,605 | 34.5 K to 24.6 K (-28.75 %) |
| Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Buy | M | 92.65 | 10,000 | 926,500 | 34,532 | 24.5 K to 34.5 K (+40.76 %) |
| Oct 08 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Option Exercise | M | 92.65 | 10,000 | 926,500 | 22,812 | |
| Oct 08 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Sell | S | 179.00 | 10,000 | 1,790,000 | 24,532 | 34.5 K to 24.5 K (-28.96 %) |
| Oct 08 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Buy | M | 95.65 | 10,000 | 956,500 | 34,532 | 24.5 K to 34.5 K (+40.76 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Option Exercise | A | 176.80 | 36,900 | 6,523,920 | 36,900 | |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Grant | A | 0.00 | 2,300 | 0 | 24,532 | 22.2 K to 24.5 K (+10.35 %) |
| Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Sell | S | 158.56 | 16 | 2,537 | 22,232 | 22.2 K to 22.2 K (-0.07 %) |
| Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Sell | S | 155.55 | 1,020 | 158,661 | 22,248 | 23.3 K to 22.2 K (-4.38 %) |
| Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Grant | A | 0.00 | 6,068 | 0 | 23,268 | 17.2 K to 23.3 K (+35.28 %) |
| Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Option Exercise | A | 93.83 | 29,600 | 2,777,368 | 29,600 | |
| Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Grant | A | 0.00 | 2,200 | 0 | 17,200 | 15 K to 17.2 K (+14.67 %) |
| Dec 18 2012 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Option Exercise | M | 92.65 | 75,000 | 6,948,750 | 75,000 | |
| Dec 18 2012 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Buy | M | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Page: 1